Eflornithine in Treating Patients With Bladder Cancer
Completed · Phase 3
Conditions studied: Bladder Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if eflornithine is more effective than no further therapy in treating bladder cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in treating patients who have newly diagnosed or recurrent bladder cancer.
Key facts
- Study ID
- NCT00003814
- Run by
- National Cancer Institute (NCI)
- People needed
- 450
- Starts
- 1999-02-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2013-12-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Intouch Research — Huntsville, Alabama, United States
- Advanced Urology Medical Center — Anaheim, California, United States
- Citrus Valley Urological Medical Group — Glendora, California, United States
- University of California San Diego Cancer Center — La Jolla, California, United States
- San Diego Urology Center — La Mesa, California, United States
- South Coast Urological Medical Group — Laguna Hills, California, United States
- Foothill Urology Associates — Pasadena, California, United States
- San Bernadino Urological Associates — San Bernadino, California, United States
- DRC and Urological Physicians of San Diego — San Diego, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Urology Specialists, P.C. — Waterbury, Connecticut, United States
- George Washington University Hospital — Washington D.C., District of Columbia, United States
- Tampa Bay Meical Research — Clearwater, Florida, United States
- University of Florida - Gainesville — Gainesville, Florida, United States
- Urology Health Center — New Port Richey, Florida, United States
- Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center — Sarasota, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Piedmont Urology PC — Atlanta, Georgia, United States
- Georgia Urology — Atlanta, Georgia, United States
- Urology Associates, Inc. — Marietta, Georgia, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Wichita Clinic, P.A. — Wichita, Kansas, United States
- Urology Associates — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.